Jonathan Lass is an Ophthalmology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 274 publications with 11,370 citations (h-index 45); ClinicalTrials.gov lists 6 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Avenue
Cleveland, OH 44106
Telephone
216-844-3601Provider last certified this registry record 10 Jan 2021.
Clinical trials
- Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
Sponsor: Case Western Reserve University
- Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss
Sponsor: Case Western Reserve University
- Life 4°C Versus Optisol in Corneal Storage Media
Sponsor: University Hospitals Cleveland Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Oyster Point Pharma, Inc.Program year20232 payments
- Oyster Point Pharma, Inc.Program year20221 payment
- PFIZER INC.Program year20211 payment$19,172openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
7 NIH research awards on record, funded 1994–2026 per NIH RePORTER. The latest:
- Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes and Other Predictors on Corneal Transplant Endothelial Cell Loss and Success
Case Western Reserve University
FY2026$752,932UG1EY037206 - Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes and Other Predictors on Corneal Transplant Endothelial Cell Loss and Success
Case Western Reserve University
FY2026$450,364UG1EY037206 - Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes and Other Predictors on Corneal Transplant Endothelial Cell Loss and Success
Case Western Reserve University
FY2025$524,992UG1EY037206
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluation of Shared Genetic Susceptibility to High and Low Myopia and Hyperopia
JAMA Ophthalmology
2021 - Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
American Journal of Ophthalmology
2019 - Factors Associated With Graft Rejection in the Cornea Preservation Time Study
American Journal of Ophthalmology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”